CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Grant or award Director acquired 39,330 shares (grant or award)
- 4 Grant or award Director acquired 23,814 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 122,804 shares at an average $1.96 ($240,522)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 3,236,290 shares at $1.44 ($4,660,258)
- 4 Option exercise 10% owner acquired 1,552,047 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 972,222 shares at $1.44 ($1,400,000)
- 4 Open-market buy 10% owner bought 1,288,339 shares at $1.44 ($1,855,208)
- 4 Open-market buy Director bought 16,502 shares at $1.44 ($23,763)
Page 16 of 28 · 551 filings